Mean Platelet Volume as Prognostic Marker in Patients with Acute Coronary Syndrome

pp. 292-298

Authors

  • Daniel A. Chirino Navarta Unidad Asistencial Por Más Salud Dr. César Milstein. Cardiology Division
  • Ariel Monteros Unidad Asistencial Por Más Salud Dr. César Milstein. Coronary Care Unit
  • Graciela Trejo Unidad Asistencial Por Más Salud Dr. César Milstein. Coronary Care Unit
  • Florencia Baglioni Unidad Asistencial Por Más Salud Dr. César Milstein. Hematology Division
  • Alicia Murua Unidad Asistencial Por Más Salud Dr. César Milstein. Hematology Division
  • Mariela S. Leonardi Unidad Asistencial Por Más Salud Dr. César Milstein. Cardiology Division
  • María L. Rodríguez Vazquez Unidad Asistencial Por Mas Salud Dr. Cesar Milstein. Cardiology Division. MTSAC Full member of the Argentine Society of Cardiology
  • Claudio Dizeo Unidad Asistencial Por Más Salud Dr. César Milstein. Cardiology Division. † To apply as Full Member of the Argentine Society of Cardiology

DOI:

https://doi.org/10.7775/rac.es.v83.i4.5545

Keywords:

Acute Coronary Syndrome - Mean Platelet Volume - Biological Markers - Prognosis - Aged

Abstract

Background: Mean platelet volume (MPV) has been described as a predictor of cardiovascular events in patients with acute coronary syndrome. However, there is limited evidence of its role as prognostic marker in elderly patients.

Objective: The aim of this study was to evaluate whether MPV is an independent predictor of events during follow-up of patients over 65 years of age with acute coronary syndrome.

Methods: This prospective study included patients over 65 years with ST-segment elevation or non ST-segment elevation acute coronary syndrome. They were divided into two groups: high MPV ( ≥ 10.9 fL- 3rd tertile) and low MPV (<10.9 fL -1st and 2nd tertile). Different clinical variables were analyzed and the TIMI and GRACE scores were calculated. The primary endpoint was the composite of all-cause mortality and cardiovascular readmission (for acute coronary syndrome, heart failure and stroke) over the follow-up period.

Results: A total of 250 patients were included in the study. Mean age was 74±7 years and 44% were women. Eighty-five patients presented with high and 165 with low MPV. Median follow-up was 302 days (interquartile range 130-558) and the primary endpoint was observed in 17.6% of cases (44 patients). In the multivariate Cox regression analysis, high MPV [HR 7.23 (95% CI 2.47-11.6); p=0.001], and TIMI [HR 3.10 (95% CI 1.46-6.59); p=0.03] and GRACE [HR 1.02 (95% CI 1.01-1.07); p=0.002] high risk scores were independent predictors of the primary endpoint. The area under the curve for MPV was 0.71 (95% CI 0.59-0.82), p=0.001.

Conclusions: In our population, MPV emerged as an independent predictor of the composite endpoint, adjusted for other variables as the TIMI and GRACE scores.

Published

2025-09-29

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)